Neocortical Lewy body counts correlate with dementia in the Lewy body variant of Alzheimer's disease

Journal of Neuropathology and Experimental Neurology

Volumn 55, Issue 1, 1996, Pages 44-52

  Samuel, William ^a   Galasko, Douglas ^a   Masliah, Eliezer ^a   Hansen, Lawrence A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Dementia; Lewy bodies; Neocortex; Neurofibrillary tangles; Senile plaques

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BRAIN BIOPSY; CLINICAL ARTICLE; FEMALE; HISTOPATHOLOGY; HUMAN; LEWY BODY; MALE; MENTAL TEST; NEUROFIBRILLARY TANGLE; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; PROGNOSIS;

EID: 0029671104     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199601000-00005     Document Type: Article

References (38)

1. Hansen LA, Masliah E, Galasko D, Terry RD. Plaque-only Alzheimer disease is usually the Lewy body variant, and vice versa. J Neuropathol Exp Neurol 1993;52:648-54
2. Terry RD, Hansen LA. DeTeresa R, et al. Senile dementia of the Alzheimer type without neocortical neurofibrillary tangles, J Neuropathol Exp Neurol 1987;46:262-68
3. Hansen L, Salmon D, Galasko D, et al. The Lewy body variant of Alzheimer's disease: A clinical and pathologic entity. Neurology 1990;40:1-8
4. Sahgal A, Galloway PH, McKeith IG, et al. Matching-to-sample deficits in patients with senile dementias of the Alzheimer and Lewy body types. Arch Neurol 1992;49:1043-46
5. Masliah E, Mallory M, DeTeresa R, et al. Differing patterns of aberrant neuronal sprouting in Alzheimer's disease with and without Lewy bodies. Brain Res 1993;617:258-66
6. Lippa CF, Smith TW, Swearer JM. Alzheimer's disease and Lewy body disease: A comparative clinicopathological study. Ann Neurol 1994;35:81-88
7. Terry RD, Masliah E, Salmon DP, et al. Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Ann Neurol 1991;30:572-80
8. Arriagada PV, Growden JH, Hedley-White ET, Hyman BT. Neurofibrillary tangles but not senile plaques parallel duration and severity in Alzheimer's disease. Neurology 1992;42:631-39
9. Bierer LM, Hof PR, Purohit DP, et al. Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease. Arch Neurol 1995;52:81-88
10. Bartus RT. Dean RL III, Beer B, Lippa AS. The cholinergic hypothesis of geriatric memory dysfunction. Science 1982;217:408-14
11. Lennox G, Lowe J, Landon M, et al. Diffuse Lewy body disease: Correlative neuropathology using anti-ubiquitin immunocytochemistry. J Neurol Neurosurg Psychiatry 1989;52:1236-47
12. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-44
13. Khachaturian Z. Diagnosis of Alzheimer's disease. Arch Neurol 1985;42:1097-1105
14. Mirra SS, Heyman A, McKeel MD, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-86
15. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82:239-59
16. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 1968;114:797-811
17. Fuld PA. Psychological testing in the differential diagnosis of the dementias. In: Katzman R, Terry RD, Bick KL, eds. Alzheimer's disease: Senile dementia and related disorders. New York: Raven Press, 1978;185-93
18. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98
19. Mattis S. Mental status examination for organic mental syndrome in the elderly patients. In: Bellack L, Karasu TB, eds. Geriatric psychiatry. New York: Grune and Stratton, 1976;77-121
20. Terry RD, Peck A, DeTeresa R, et al. Some morphometric aspects of the brain in senile dementia of the Alzheimer type. Ann Neurol 1981;10:184-92
21. Kuzuhara S, Mori H, Izumiyama N, et al. Lewy Bodies are ubiquitinated: A light and electron microscopic immunocytochemical study. Acta Neuropathol 1988;75:345-53
22. Lennox G, Lowe J, Morrell K, et al. Antiubiquitin immunocytochemistry is more sensitive than conventional techniques in the detection of diffuse Lewy body disease. J Neurol Neurosurg Psychiatry 1989;52:67-71
23. Lowe J. Lewy bodies. In Calne DF, ed. Neurodegenerative diseases. Philadelphia: WB Saunders, 1994
24. Masliah E, Mallory M, Hansen L, Alford M, DeTeresa R, Terry R. An antibody against phosphorylated neurofilaments identifies a subset of damaged association axons in Alzheimer's disease. Am J Pathol 1993;142:871-82
25. Statview + Graphics. Abacus Concepts. Berkeley, CA; 1988
26. Banshor C, Braak H, Fischer P, Jellinger KA. Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer's and Parkinson's disease patients. Neurosci Lett 1993;162:179-82
27. Perry EK, McKeith I, Thompson P, et al. Topography, extent, and clinical relevance of neurochemical deficits in dementia of Lewy body type, Parkinson's disease, and Alzheimer's disease. Ann NY Acad Sci 1991;640:197-202
28. Hansen LA, Galasko D. Lewy body disease. Curr Opin Neurol Ncurosurg 1992;5:889-94
29. Samuel W, Terry RD, DeTeresa RD, Masliah E. Clinical correlates of cortical and nucleus basalis pathology in Alzheimer's dementia. Arch Neurol 1994;51:772-78
30. Saitoh T, Xia MS, Chen MD, et al. The CYP2D6B mutuant allele is overrepresented in the Lewy body variant of Alzheimer's disease. Ann Neurol 1995;37:110-12
31. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-84
32. Schmidt ML, Murray J, Lee VM-Y, et al. Epitope map of neurofilament protein domains in cortical and peripheral nervous system Lewy bodies. Am J Pathol 1991;139:53-65
33. Kuljis R, Martin-Vasallo P, Peress N. Lewy bodies in tyrosine hydroxylase-synthesizing neurons of the human cerebral cortex. Neurosci Lett 1989;106:49-54
34. Masliah E, Mallory M, Hansen L, et al. Quantitative alterations in the human neocortex during normal aging. Neurology 1993;43: 192-97
35. Zhau S-S, Beyreuther K, Schmitt HP. Quantitative assessment of the synaptophysin immunoreactivity of the cortical neuropil in various neurodegenerative disorders with dementia. Dementia 1993;4: 66-74
36. Nishimura M, Tomimoto H, Suenaga T, et al. Synaptophysin and chromogranin A immunoreactivities of Lewy bodies in Parkinson's disease brains. Brain Res 1994;634:339-44
37. Wakabayashi K, Honer WG, Masliah E. Synapse alterations in the hippocampal-entorhinal formation in Alzheimer's disease with and without Lewy body disease. Brain Res 1994;667:24-32.
38. 4 is overrepresented in patients with the Lewy body variant of Alzheimer's disease. Neurology 1994;44:1950-51